அடார் பூனாவல்ல வழிநடத்தியது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Covishield maker SII seeks indemnity from liability Covishield maker SII seeks indemnity from liability IANS / Updated: Jun 4, 2021, 09:06 IST #NEWDELHI Pune-based Serum Institute of India (SII), which manufactures Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources. This comes as the Centre is favourably considering granting indemnity against legal proceedings to foreign vaccine makers Pfizer and Moderna prior to their rollout in India. “All vaccine makers, whether Indian or foreign, should be granted the same protection,” the Adar Poonawalla-led company has reportedly told the government. “Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it,” it further said. It is learnt that Serum is hoping that rules should be same for everyone. The Serum Institute produces Covishield (the Indian name f

United kingdomOxford astrazeneca covishieldNovovax covovaxSerum instituteSerum institute of indiaAdar poonawalla ledDrug controller generalEmergency use authorisationSerum institute of india siiRussian sputnikv covid 19 vaccineForeign vaccine pfizerEmergency use authorisation euaAstrazeneca oxford jabAnti covid vaccinesஒன்றுபட்டது கிஂக்டம்சீரம் நிறுவனம்